Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chung-Jing Wang, M.D.
St. Martin De Porres Hospital
Study Chair - Kuan-Yu Hung, M.D. & Ph.D.
Nephrology Section, Department of Internal Medicine, National Taiwan University and College of Medicine
Principal Investigator - Pau-Chung Chen, M.D. & Ph.D.
Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hemodialysis Center, St. Martin de Porres Hospital
Chiayi City, Taiwan
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2007
- Primary completion
- 29 Feb 2008
- Completion
- 31 Mar 2008
- Last update posted
- 5 May 2016
- Registered enrollment
- 200
- Registry id
- NCT00527774
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.